ULGX Share Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
ULGX Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
CSCO 33.74 0.42%
CSCO 33.74 0.42%
NASDAQ USA Top Gainers Stocks
EDMC 0.02 100.00%
LIWA 0.02 100.00%
QKLS 0.20 100.00%
MOSY 3.50 54.19%
LOCM 0.09 50.00%
MYRX 0.06 50.00%
LMIA 13.66 48.64%
CPSL 0.10 42.86%
WRES 0.09 28.57%
BSDM 0.62 26.53%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%

Urologix, Inc. (NASDAQ: ULGX)

ULGX Technical Analysis 1
As on N/A ULGX Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
ULGX Target for February
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ULGX Other Details
Segment EQ
Market Capital 16210637.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.urologix.com
ULGX Address
14405 21st Avenue North
Suite 110
Minneapolis, MN 55447
United States
Phone: 763-475-1400
Fax: 763-404-8118
ULGX Latest News
Week Ahead   Ocala   - 19th Feb 17
Netflix, Amazon fuel LA office demand   NorthJersey.com   - 17th Feb 17
Vermilion Energy Inc (VET) To Go Ex-Dividend on February 21st   Sports Perspectives   - 16th Feb 17
CJ Extra calendar: Topeka's upcoming meetings and events, Feb.15-21   Topeka Capital Journal   - 15th Feb 17
North Broadway fire contained   KFDI   - 13th Feb 17
Governing bodies to take up road widening, city manager search   Topeka Capital Journal   - 29th Jan 17
21st North Inc. (formerly known as Urologix, Inc.) Announces Expected Timeline ...   GlobeNewswire (press release)   - 26th Apr 16
21st North Inc. Announces Special Meeting of Shareholders to Approve the Plan ...   GlobeNewswire (press release)   - 30th Mar 16
Urologix sold to settle debt to Medtronic   Mass Device   - 03rd Feb 16
Urologix Announces Sale of Operating Assets to Private Company Buyer   GlobeNewswire (press release)   - 03rd Feb 16
Interactive Technical Analysis Chart Urologix, Inc. ( ULGX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Urologix, Inc.
ULGX Business Profile
Urologix, Inc. (Urologix) develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH). These therapies use technology in the treatment of BPH, a disease that affects more than 30 million men worldwide and is the most common prostate problem for men over 50. It markets both the Cooled ThermoTherapy (CTT) product line and the Prostiva Radio Frequency (RF) Therapy System. The Prostiva RF Therapy System delivers radio frequency energy directly into the prostate through the use of insulated electrodes deployed from a transurethral scope, ablating targeted prostatic tissue under the direct visualization of the urologist. These focal ablations reduce constriction of the urethra, thereby relieving BPH voiding symptoms. It acquired the worldwide license to the Prostiva RF Therapy System, in September 2011.